miR-149-3p reverses CD8+ T-cell exhaustion by reducing inhibitory receptors and promoting cytokine secretion in breast cancer cells M Zhang, D Gao, Y Shi, Y Wang, R Joshi, Q Yu, D Liu, F Alotaibi, Y Zhang, ... Open Biology 9 (10), 190061, 2019 | 50 | 2019 |
Supplementing preservation solution with mitochondria-targeted H2S donor AP39 protects cardiac grafts from prolonged cold ischemia–reperfusion injury in heart transplantation C Zhu, Y Su, S Juriasingani, H Zheng, V Veramkovich, J Jiang, A Sener, ... American Journal of Transplantation 19 (11), 3139-3148, 2019 | 49 | 2019 |
miRNA-5119 regulates immune checkpoints in dendritic cells to enhance breast cancer immunotherapy M Zhang, Y Shi, Y Zhang, Y Wang, F Alotaibi, L Qiu, H Wang, S Peng, ... Cancer Immunology, Immunotherapy 69, 951-967, 2020 | 42 | 2020 |
CD5 blockade enhances ex vivo CD8+ T cell activation and tumour cell cytotoxicity F Alotaibi, M Rytelewski, R Figueredo, R Zareardalan, M Zhang, ... European Journal of Immunology, 2020 | 32 | 2020 |
Role of exosomes in biological communication systems FA Alzahrani, IM Saadeldin Springer, 2021 | 20 | 2021 |
Type I interferon autoantibodies in hospitalized patients with Middle East respiratory syndrome and association with outcomes and treatment effect of interferon beta‐1b in … F Alotaibi, NK Alharbi, LB Rosen, AY Asiri, AM Assiri, HH Balkhy, ... Influenza and Other Respiratory Viruses 17 (3), e13116, 2023 | 17 | 2023 |
Exosomal microRNAs in cancer: Potential biomarkers and immunotherapeutic targets for immune checkpoint molecules F Alotaibi Frontiers in Genetics 14, 1052731, 2023 | 9 | 2023 |
Reduced CD5 on CD8+ T Cells in Tumors but Not Lymphoid Organs Is Associated With Increased Activation and Effector Function F Alotaibi, M Vincent, WP Min, J Koropatnick Frontiers in Immunology 11, 584937, 2021 | 6 | 2021 |
The risk factors for acute cerebrovascular accident (stroke) in patients with severe acute respiratory syndrome coronavirus (SARS-CoV-2) BA Alotaibi, JA Aldali, HJ Aldali, SA Meo, GA Alasiri, EM Elsokkary, ... Viruses 15 (5), 1140, 2023 | 2 | 2023 |
Destabilizing the genome as a therapeutic strategy to enhance response to immune checkpoint blockade: a systematic review of clinical trials evidence from solid and … F Alotaibi, K Alshammari, BA Alotaibi, H Alsaab Frontiers in Pharmacology 14, 1280591, 2024 | 1 | 2024 |
Antibiotic exposure concurrently with anti-PD1 blockade therapy reduces overall survival in patients with child–Pugh class A advanced hepatocellular carcinoma K Alshammari, FM Alotaibi, F Alsugheir, M Aldawoud, A Alolayan, ... Cancers 16 (1), 133, 2023 | 1 | 2023 |
Exosomal microRNAs: Potential biomarkers for cancer diagnosis, treatment response and prognosis F Alotaibi Role of exosomes in biological communication systems, 321-336, 2021 | 1 | 2021 |
The impact of antibiotic use in gastrointestinal tumors treated with immune checkpoint inhibitors: systematic review and meta-analysis FM Alotaibi, IAS Albalawi, AM Anis, H Alotaibi, S Khashwayn, ... Frontiers in Medicine 11, 1415093, 2024 | | 2024 |
Fes-deficient macrophages enhance CD8+ T cell priming and tumour control through increased proinflammatory cytokine production and presentation BJ Laight, D Harper, N Dmytryk, S Zhang, A Garven, C Shi, R Nauman, ... bioRxiv, 2024.02. 27.581601, 2024 | | 2024 |
CD5 blockade, a novel immune checkpoint inhibitor, enhances T cell anti-tumour immunity and delays tumour growth in mice harbouring poorly immunogenic 4T1 breast tumour homografts FM Alotaibi, WP Min, J Koropatnick Frontiers in Immunology 15, 1256766, 2024 | | 2024 |
Outcomes and prognostic factors of advanced biliary tract cancers in Saudi Arabia. K Alshammari, R Alduaiji, L Alotaibi, R Alqadiri, L Alqahtani, F Alotaibi, ... Journal of Clinical Oncology 42 (3_suppl), 460-460, 2024 | | 2024 |
P-361 Safety and efficacy of short cetuximab infusion for patients with metastatic colorectal cancer K Alshammari, R Alanazi, MM Ali, A Abushara, A Al-Abdulaali, F Alotaibi, ... Annals of Oncology 34, S141, 2023 | | 2023 |
P-297 Clinical characteristics and outcomes of patients with hepatocellular carcinoma treated at a large multidisciplinary clinic in Saudi Arabia K Alshammari, A Alammar, A Alrashdi, H Alrajih, N Algazlan, J Altwalah, ... Annals of Oncology 34, S120, 2023 | | 2023 |
P-254 Outcomes and prognostic factors of resected pancreatic ductal adenocarcinoma in Saudi Arabia K Alshammari, A Samman, F Alotaibi, F Almugbel, A Aldeheshi, ... Annals of Oncology 34, S105, 2023 | | 2023 |
Outcomes of molecular tumor board recommendations for cancer patients with progression on standard of care therapies in Saudi Arabia M Alshammari, K., Sabatin, F., Hazar-Rethinam, M., Alotaibi, F., Ajina, R ... Cancer Research 83, 938-938., 2023 | | 2023 |